Last reviewed · How we verify
glutamine supplementation
At a glance
| Generic name | glutamine supplementation |
|---|---|
| Also known as | Glutamine |
| Sponsor | Hospital General de Mexico |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pre-Surgical Immunonutrition's Effect on Colorectal Surgery (NA)
- Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability (NA)
- Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients. (NA)
- Perioperative Nutrition Optimization for Reducing Complications After Surgical Fracture Fixation (PHASE3)
- Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy (NA)
- Oral Supplement and Acute Resistance Exercise (NA)
- Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT) (PHASE2)
- Essential Amino Acid Supplementation for Femoral Fragility Fractures (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- glutamine supplementation CI brief — competitive landscape report
- glutamine supplementation updates RSS · CI watch RSS
- Hospital General de Mexico portfolio CI